Published TCIMAIL newest issue No.200
Maximum quantity allowed is 999
Boronic acids are recognized as useful scaffolds for pharmaceutical compounds, due to their unique property to form a reversible covalent bond at the boron center with various nucleophilic functional groups. Particularly, benzoxaboroles have gathered much interest as a boron-containing scaffold for bioactive compounds such as tavaborole (leucyl-tRNA synthetase inhibitor) and crisaborole (PDE4 inhibitor), with unique mechanisms of action.1,2) We offer a wide range of benzoxaboroles with various functional groups on each benzene ring useful for further derivatizations like 1, 2, 3, 4, 5, 6 and 7,3,4) and we also can provide custom synthesis of derivatives including bulk synthesis.
